Search results
Pfizer to test third dose of COVID-19 vaccine in children
AOL· 5 days agoThe decision was made after an analysis showed the two-dose vaccine generated an immune response in...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 5 days agoThe RS Rating measures a stock's 12-month running performance against all other stocks. That RS...
Spotlight on Pfizer: Analyzing the Surge in Options Activity - Pfizer (NYSE:PFE)
Benzinga· 4 days agoWhile it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include..., ...
Novavax stock skyrockets 120% on $1.2 billion vaccine deal with Sanofi
Quartz· 3 days agoUnder the terms of the agreement, Sanofi will begin to book sales of Novavax’s COVID-19 vaccine...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 5 days agoModerna is rivaling vaccine makers Pfizer and Novavax. Still, the market for Covid boosters is...
Leerink Partnrs Comments on Pfizer Inc.’s Q2 2024 Earnings (NYSE:PFE)
ETF DAILY NEWS· 6 days agoPfizer Inc. (NYSE:PFE – Free Report) – Stock analysts at Leerink Partnrs upped their Q2 2024 earnings estimates for Pfizer in a report issued on Thursday ...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 4 days agoBut as society learned to live with Covid...reached a recent low at 2590.87 on April 25, down 15%...
The 3 Most Undervalued Healthcare Stocks to Buy in May 2024
InvestorPlace· 3 days agoA commonly used strategy for investing is sector rotation. A good example is the flow of funds into...
3 Profitable Dividend Stocks to Buy at Near-Lows
InvestorPlace· 4 days agoWith high yields above 3% and dirt-cheap valuations, these undervalued dividend stocks present a significant margin of safety.
Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare
InvestorPlace· 6 days agoInvestors concerned about broader market undulations may want to consider the resilience narrative...